MEDIFAST INC - Common Stock, par value $0.001 per share (MED)

Historical Holders from Q1 2014 to Q1 2025

Symbol
MED on NYSE
CUSIP
58470H101
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
10.9M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
8.92M
Holdings value
$157M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
131
Number of buys
47
Number of sells
-75
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of MEDIFAST INC - Common Stock, par value $0.001 per share (MED)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RENAISSANCE TECHNOLOGIES LLC 9.2% $13.6M 1.01M Renaissance Technologies LLC Sep 30, 2024

Institutional Holders of MEDIFAST INC - Common Stock, par value $0.001 per share (MED)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 107K $1.45M -$334K $13.48 12
2024 Q4 8.92M $157M -$4.3M $17.62 131
2024 Q3 9.16M $175M -$26.8M $19.14 142
2024 Q2 10.4M $228M -$54M $21.82 159
2024 Q1 11.5M $440M +$25.2M $38.32 187
2023 Q4 10M $675M +$43.6M $67.22 210
2023 Q3 9.57M $717M -$5.17M $74.85 217
2023 Q2 9.57M $883M -$72M $92.16 229
2023 Q1 10.2M $1.06B +$87M $103.67 259
2022 Q4 9.18M $1.06B -$14.4M $115.35 268
2022 Q3 9.51M $1.03B -$58.3M $108.36 241
2022 Q2 9.64M $1.74B -$23.4M $180.51 265
2022 Q1 9.89M $1.69B +$21.5M $170.78 275
2021 Q4 9.72M $2.04B -$39.1M $209.43 289
2021 Q3 9.99M $1.92B -$28.2M $192.64 285
2021 Q2 9.97M $2.82B +$76.8M $282.98 295
2021 Q1 9.73M $2.06B -$49.7M $211.82 270
2020 Q4 9.99M $1.96B -$26.7M $196.34 252
2020 Q3 10.1M $1.65B -$250M $164.45 232
2020 Q2 12.1M $1.68B -$32.9M $138.77 216
2020 Q1 12.4M $774M -$72.2M $62.50 183
2019 Q4 13.3M $1.46B +$25.6M $109.58 208
2019 Q3 13.1M $1.36B +$132M $103.63 227
2019 Q2 11.6M $1.49B -$1.88M $128.30 241
2019 Q1 11.8M $1.51B +$73.4M $127.55 238
2018 Q4 11.2M $1.4B +$7.15M $125.02 234
2018 Q3 10.8M $2.4B +$107M $221.55 259
2018 Q2 10.5M $1.69B -$6.56M $160.16 246
2018 Q1 10.7M $999M +$24.9M $93.45 211
2017 Q4 10.5M $733M +$10.6M $69.81 195
2017 Q3 10.4M $616M -$9.97M $59.37 168
2017 Q2 10.6M $440M -$14.9M $41.47 157
2017 Q1 10.9M $482M +$70.7M $44.37 164
2016 Q4 10.5M $438M +$8.33M $41.63 157
2016 Q3 10.3M $389M +$4.9M $37.79 159
2016 Q2 10.2M $340M -$417K $33.27 150
2016 Q1 10.1M $304M +$18.6M $30.19 127
2015 Q4 9.48M $288M +$9.88M $30.38 123
2015 Q3 9.18M $247M -$23.8M $26.86 114
2015 Q2 10M $323M -$6.25M $32.32 123
2015 Q1 10.3M $309M +$4.09M $29.97 123
2014 Q4 10.2M $341M -$1.7M $33.55 125
2014 Q3 10.2M $336M -$69M $32.83 127
2014 Q2 12.4M $378M -$4.46M $30.41 132
2014 Q1 12.6M $368M +$28.6M $29.09 132